🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › Distaarikii Koloombiyaa

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Distaarikii Koloombiyaa keessatti

Qorannoo 4 Leukemia Biphenotypicii Hamaa f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.